Description
Diabetes is a condition that affects the metabolism of glucose, or sugar, in the body. There are several medications that are typically prescribed to patients with diabetes, two of those are ertugliflozin and sitagliptin. Ertugliflozin is a member of the SGLT2 inhibitors class of drugs. These drugs work by blocking the enzyme SGLT2, which is responsible for helping your kidneys reabsorb glucose from your urine. By blocking this enzyme, ertugliflozin increases the excretion of glucose through urine, which in turn helps to lower blood sugar levels.
Ingredients
Ertugliflozin, Sitagliptin
Uses
Ertugliflozin, Sitagliptin combination is utilized for the following therapeutic indications:
- Treatment of type 2 diabetes mellitus in adults, improving glycemic control.
- Provides dual mechanisms of action for better blood sugar management.
- May help in weight management and lowering cardiovascular risks.
Reviews
There are no reviews yet.